200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 145307-34-2

145307-34-2

145307-34-2 | 1H-2-Benzopyran-5,6-diol, 1-(aminomethyl)-3,4-dihydro-3-tricyclo[3.3.1.13,7]dec-1-yl-, hydrochloride (1:1), (1R,3S)-

CAS No: 145307-34-2 Catalog No: AG001KS5 MDL No:

Product Description

Catalog Number:
AG001KS5
Chemical Name:
1H-2-Benzopyran-5,6-diol, 1-(aminomethyl)-3,4-dihydro-3-tricyclo[3.3.1.13,7]dec-1-yl-, hydrochloride (1:1), (1R,3S)-
CAS Number:
145307-34-2
Molecular Formula:
C20H28ClNO3
Molecular Weight:
365.8942
IUPAC Name:
(1R,3S)-3-(1-adamantyl)-1-(aminomethyl)-3,4-dihydro-1H-isochromene-5,6-diol;hydrochloride
InChI:
InChI=1S/C20H27NO3.ClH/c21-10-17-14-1-2-16(22)19(23)15(14)6-18(24-17)20-7-11-3-12(8-20)5-13(4-11)9-20;/h1-2,11-13,17-18,22-23H,3-10,21H2;1H/t11?,12?,13?,17-,18-,20?;/m0./s1
InChI Key:
BWHPNJVKFAPVOG-QYFJGNGUSA-N
SMILES:
NCC1OC(Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3.Cl
UNII:
WA6RGP1J4W

Properties

Complexity:
454  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
365.176g/mol
Formal Charge:
0
Heavy Atom Count:
25  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
365.898g/mol
Monoisotopic Mass:
365.176g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
75.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats. The international journal of neuropsychopharmacology 20090801
Neonatal tactile stimulation enhances spatial working memory, prefrontal long-term potentiation, and D1 receptor activation in adult rats. Neurobiology of learning and memory 20080501
Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors. Neuropharmacology 20070201
Effect of dopamine D1 receptor antagonist SCH23390 and D1 agonist A77636 on active allothetic place avoidance, a spatial cognition task. Behavioural brain research 20060925
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
The anorectic effect of the selective dopamine D1-receptor agonist A-77636 determined by meal pattern analysis in free-feeding rats. European journal of pharmacology 20060227
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Molecular pharmacology 20051001
Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biological psychiatry 20050601
Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. The Journal of pharmacology and experimental therapeutics 20041001
The actions of a D-1 agonist in MPTP treated primates show dependence on both D-1 and D-2 receptor function and tolerance on repeated administration. Journal of neural transmission (Vienna, Austria : 1996) 20020201
Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology 20020101
Rewarding and locomotor-activating effects of direct dopamine receptor agonists are augmented by chronic food restriction in rats. Psychopharmacology 20010401
Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat. Brain research 20010302
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys. Neurology 19970801
Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo. Journal of medicinal chemistry 19970523
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus). Movement disorders : official journal of the Movement Disorder Society 19951101
Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys. The Journal of pharmacology and experimental therapeutics 19931001

Related Products

© 2019 Angene International Limited. All rights Reserved.